Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801

Pyramidal Cell Selective Ablation of N-Methyl-D-Aspartate Receptor 1 Causes Increase in Cellular and Network Excitability

(2015) Valerie M. Tatard-Leitman et al.   BIOLOGICAL PSYCHIATRY

Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia

(2015) Shigeyuki Chaki et al.   PSYCHOPHARMACOLOGY

The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia

(2015) Samuel M. Cohen et al.   SCHIZOPHRENIA RESEARCH

GABA circuitry, cells and molecular regulation in schizophrenia: Life in the graveyard

(2015) Paul J. Harrison   SCHIZOPHRENIA RESEARCH

A parvalbumin-positive excitatory visual pathway to trigger fear responses in mice

(2015) C. Shang et al.   SCIENCE

Parvalbumin Cell Ablation of NMDA-R1 Causes Increased Resting Network Excitability with Associated Social and Self-Care Deficits

(2014) Eddie N Billingslea et al.   NEUROPSYCHOPHARMACOLOGY

Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists

(2014) Laura Pozzi et al.   PLoS One

Knockout of NMDA Receptors in Parvalbumin Interneurons Recreates Autism-Like Phenotypes

(2013) John A. Saunders et al.   Autism Research

Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons

(2013) Zhihong Jiang et al.   BIOLOGICAL PSYCHIATRY

GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice

(2013) P S Suryavanshi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes

(2013) Gregory R. Rompala et al.   PLoS One

Anxiety comorbidity in schizophrenia

(2013) Raphael J. Braga et al.   PSYCHIATRY RESEARCH

Cortical basket cell dysfunction in schizophrenia

(2012) Allison A. Curley et al.   JOURNAL OF PHYSIOLOGY-LONDON

Dissecting spatial knowledge from spatial choice by hippocampal NMDA receptor deletion

(2012) David M Bannerman et al.   NATURE NEUROSCIENCE

Examining the genetic and neural components of cognitive flexibility using mice

(2012) Jonathan L. Brigman et al.   PHYSIOLOGY & BEHAVIOR

NMDA Receptor and Schizophrenia: A Brief History

(2012) J. T. Coyle   SCHIZOPHRENIA BULLETIN

NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia

(2012) G. Gonzalez-Burgos et al.   SCHIZOPHRENIA BULLETIN

Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?

(2011) John Lisman   CURRENT OPINION IN NEUROBIOLOGY

Imaging of Thalamocortical Dysrhythmia in Neuropsychiatry

(2011) Joshua J. Schulman et al.   Frontiers in Human Neuroscience

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior

(2011) M Carlén et al.   MOLECULAR PSYCHIATRY

Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory

(2011) Andrew J Murray et al.   NATURE NEUROSCIENCE

GABAergic interneuron origin of schizophrenia pathophysiology

(2011) Kazu Nakazawa et al.   NEUROPHARMACOLOGY

A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory

(2011) Janice W. Smith et al.   PSYCHOPHARMACOLOGY

NMDA Receptor Ablation on Parvalbumin-Positive Interneurons Impairs Hippocampal Synchrony, Spatial Representations, and Working Memory

(2010) Tatiana Korotkova et al.   NEURON

MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?

(2010) Joshua D. Vardigan et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia

(2009) BKY Bitanihirwe et al.   BMC Psychiatry

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

(2009) Juan E Belforte et al.   NATURE NEUROSCIENCE

N-Methyl-D-Aspartate Receptor and Calbindin-Containing Neurons in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder

(2008) Tsung-Ung W. Woo et al.   BIOLOGICAL PSYCHIATRY

Losing inhibition with ketamine

(2008) Jeremy Seamans   Nature Chemical Biology

The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats

(2008) Andrea Bari et al.   Nature Protocols

Contribution of Hippocampal and Extra-Hippocampal NR2B-Containing NMDA Receptors to Performance on Spatial Learning Tasks

(2008) Jakob von Engelhardt et al.   NEURON

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

(2008) John E. Lisman et al.   TRENDS IN NEUROSCIENCES

Dorsal hippocampal N-methyl-d-aspartate receptors underlie spatial working memory performance during non-matching to place testing on the T-maze

(2007) Stephen B. McHugh et al.   BEHAVIOURAL BRAIN RESEARCH